July 23, 2009
Acuvail approved for post-cataract surgery pain and inflammation
Acuvail is formulated at pH 6.8 to enable deionized drug delivery on the corneal surface, is preservative-free, and contains carboxymethylcellulose, which enables the drug to adhere to the ocular surface. Acuvail is expected to be available in September 2009 in a 0.45% strength.
For more information call (800) 433-8871 or visit www.allergan.com.